225526-17-0
中文名称
225526-17-0
英文名称
3-Piperidinamine, N-[[3,4-dihydro-6-methoxy-1-methyl-1-(trifluoromethyl)-1H-2-benzopyran-7-yl]methyl]-2-phenyl-, (2S,3S)-
CAS
225526-17-0
分子式
C24H29F3N2O2
分子量
434.49
MOL 文件
225526-17-0.mol
结构式
基本信息
中文别名
SUBSTANCE P RECEPTOR ANTAGONIST 1
英文别名
Substance P Receptor Antagonist 1
3-Piperidinamine, N-[[3,4-dihydro-6-methoxy-1-methyl-1-(trifluoromethyl)-1H-2-benzopyran-7-yl]methyl]-2-phenyl-, (2S,3S)-
3-Piperidinamine, N-[[3,4-dihydro-6-methoxy-1-methyl-1-(trifluoromethyl)-1H-2-benzopyran-7-yl]methyl]-2-phenyl-, (2S,3S)-
物理化学性质
| 沸点 | 511.0±50.0 °C(Predicted) |
| 密度 | 1.23±0.1 g/cm3(Predicted) |
| 储存条件 | -20°C储存 |
| 溶解度 | 溶于二甲基亚砜 |
| 酸度系数(pKa) | 9.15±0.10(Predicted) |
常见问题列表
生物活性
Substance P Receptor Antagonist 1 在中枢神经系统疾病，呼吸疾病和炎症以及肠胃失调等方面具有潜在的作用。
体外研究
Substance P Receptor Antagonist 1 has the potential function in numerous diseases, including central nervous system disorders such as depression, anxiety and schizophrenia, in respiratory and inflammatory diseases such as asthma and rheumatoid arthritis, in gastrointestinal disorders and diseases of the GI tract such as ulcerative colitis and Crohn's disease, and in the transmission of pain, including migraine.